Dental age estimation: A comparative study of convolutional neural network and Demirjian's method.

The aim of this study is to compare a technique using Convolutional Neural Network (CNN) with the Demirjian's method for chronological age estimation of living individuals based on tooth age from panoramic radiographs. This research used 5898 panoramic X-ray images collected for diagnostic from pediatric patients aged 4-17 who sought treatment at Antalya Oral and Dental Health Hospital between 2015 and 2020. The Demirjian's method's grading was executed by researchers who possessed appropriate training and experience. In the CNN method, various CNN architectures including Alexnet, VGG16, ResNet152, DenseNet201, InceptionV3, Xception, NASNetLarge, InceptionResNetV2, and MobieNetV2 have been evaluated. Densenet201 exhibited the lowest MAE value of 0.73 years, emphasizing its superior accuracy in age estimation compared to other architectures. In most age categories, the predicted age closely matches the actual age. The most inconsistent results are observed at ages 12 and 13. The results highlight correspondence between the age predicted by CNN and the Demirjian's approach. In conclusion, the results show that the CNN method is adequate to be an alternative to the Demirjian's age estimation method. We suggest that convolutional neural network can effectively optimize the accuracy of age estimation and can be faster than traditional methods, eliminating the need for additional learning from experts.

Evaluation of retinal alterations in Parkinson disease and tremor diseases.

Optical coherence tomography (OCT) has been suggested as a method for detection of retinal alterations in neurodegenerative diseases. The usefulness of OCT as a diagnostic tool to differentiate Parkinson's disease (PD) from other tremor diseases, remains unknown. We aimed to evaluate morphological changes of the retina in patients with PD, essential tremor (ET), essential tremor-Parkinson's disease (ET-PD) using OCT. Forty-two eyes of 21 patients with PD, 24 eyes of 12 patients with ET, 24 eyes of 12 patients with ET-PD and 44 eyes of 22 age-matched healthy controls were included in the study. All participants underwent detailed neurological and ophthalmological examination. Measurements in all quadrants of macula and retinal nerve fiber layer (RNFL) thickness using OCT were recorded. There was no significant difference among the groups regarding age, sex. The average RNFL thickness was thinner in PD patients than that of ET (p = 0.032). The RNFL thickness in superior quadrant was lower in PD group compared with the ET and control group (p = 0.001, p = 0.016). Significant differences were observed in most of the macular thickness parameters excluding foveolar and foveal thickness (p = 0.865, 0.394). Correlations were found among several OCT parameters and disease duration or severity in all patient groups (p > 0.05). Retinal alterations were found in PD patients compared to ET. However, no significant retinal changes were detected by OCT in patients with ET and ET-PD compared to controls. According to our data, retinal assessments by OCT do not seem to be satisfactory for differentiation of these disorders.

Autologous Platelet-Rich Fibrin in the Treatment of Refractory Macular Holes.

PURPOSE: To describe a novel method for the treatment of refractory macular holes. METHODS: Two case reports on the use of autologous platelet rich fibrin (PRF), followed by sulfur hexafluoride gas tamponade to facilitate closure of refractory macular holes. RESULTS: Macular holes were succesfully closed within a week in both cases. Best corrected Snellen visual acuities improved from counting fingers to 0.16 in the first case, and from 0.05 to 0.2 in the second case. No complication occurred during or after the procedures. CONCLUSION: The use of autologous PRF seems to be a safe and effective alternative method for the treatment of refractory macular holes. Further experience and studies are required to assess the value of autologous PRF in the management of challenging macular hole cases of different etiologies. To the best of our knowledge, this is the first use of autologous PRF in the treatment of macular holes.